EUVIMEDEUVIMED entdecken
Scoping ReviewStudienprotokollOpen Access · CC BY 4.0

Mapping the role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptors in chronic kidney disease: A scoping review protocol

Hansani Niroshika iD, Harshi Weerakoon, Nalaka Herath, Kosala Weerakoon, Prasad Jayasooriya

PLOS One · 07.04.2026 · 21 (4) · e0330796

DOI: 10.1371/journal.pone.0330796 ↗

Kurz gefasst

Scoping Review in der Zeitschrift PLOS One, online erschienen am 07.04.2026. Verfasst von Hansani Niroshika und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Graduate Studies, General Sir John Kotelawala Defence University, Ratmalana, Sri Lanka. Hauptthemen laut MEDLINE: TNF-Related Apoptosis-Inducing Ligand, Renal Insufficiency, Chronic, Receptors, TNF-Related Apoptosis-Inducing Ligand. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asian Development Bank.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is increasingly recognized as a global public health concern, impacting about 800 million people worldwide. Despite having different CKD etiologies, apoptosis, inflammation and fibrosis are the central mechanisms of pathogenesis. Tumor necrosis factor (TNF)- related apoptosis-inducing ligand (TRAIL) is a critical regulator of these mechanisms, suggesting a prominent role in pathogenesis and progression of CKD. Therefore, systematic mapping of the available evidence is pivotal in identifying the exact role of TRAIL and its receptors in CKD. The proposed scoping review will be conducted in line with Arksey and O’Malley’s methodological framework and the Joanna Briggs Institute (JBI) reviewer’s manual. Accordingly, the review will be guided by the five-stage approach, namely (1) identify the research question; (2) identify relevant studies; (3) select studies; (4) chart the data; and (5) collate, summarize, and report the results. Eligibility criteria and search strategies will be formulated based on population, concept, and context (PCC) strategy. Articles published up to January 2026 will be searched using electronic databases (PubMed/ MEDLINE, Science Direct, Scopus, CINAHL, EMBASE, Web of Science and Cochrane Library) and clinical trial registries (ClinicalTrials.gov and WHO ICTRP). Reference lists of relevant reviews retrieved from Google Scholar will also be screened for grey literature. A formal quality appraisal of the selected studies will be conducted using the mixed-method appraisal tool (MMAT version 2018). The reporting will be done following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for the Scoping Reviews checklist. The literature search is expected to commence in March 2026, followed by study selection and data extraction by April 2026. Data synthesis will be completed by June 2026. The review protocol is registered at Open Science Framework (OSF) under https://doi.org/10.17605/OSF.IO/AENBX .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TNF-Related Apoptosis-Inducing LigandRenal Insufficiency, ChronicReceptors, TNF-Related Apoptosis-Inducing LigandHumansScoping Reviews as TopicApoptosis

Substanzen

TNF-Related Apoptosis-Inducing LigandReceptors, TNF-Related Apoptosis-Inducing Ligand

Autor:innen und Institutionen

  • Faculty of Graduate Studies, General Sir John Kotelawala Defence University, Ratmalana, Sri Lanka.
  • Department of Bioprocess Technology, Faculty of Technology, Rajarata University of Sri Lanka, Mihintale, Sri Lanka.
  • Department of Biochemistry, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka.
  • Colombo North Teaching Hospital, Ragama, Sri Lanka.
  • Department of Parasitology, Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura, Sri Lanka.

ORCID-Profile: Hansani Niroshika

Förderung

  • Asian Development Bank

Zitieren

APA

Niroshika, H., Weerakoon, H., Herath, N., Weerakoon, K., & Jayasooriya, P. (2026). Mapping the role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptors in chronic kidney disease: A scoping review protocol. PLOS One, 21(4), e0330796. https://doi.org/10.1371/journal.pone.0330796

Vancouver

Niroshika H, Weerakoon H, Herath N, Weerakoon K, Jayasooriya P. Mapping the role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptors in chronic kidney disease: A scoping review protocol. PLOS One. 2026;21(4):e0330796. doi:10.1371/journal.pone.0330796

BibTeX
@article{Niroshika2026,
  author = {Niroshika, Hansani and Weerakoon, Harshi and Herath, Nalaka and Weerakoon, Kosala and Jayasooriya, Prasad},
  title = {Mapping the role of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and its receptors in chronic kidney disease: A scoping review protocol},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0330796},
  doi = {10.1371/journal.pone.0330796}
}
Kostenlos starten →